INNT
TOTAL INVALIDATION PROCESSED BY THE IB
25/12/2025
Voltar para busca
Dado oficial do USPTO
ALG PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
26/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
07/07/2016
Data de registro
17/04/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/11/2024
Última transação
26/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
FR
Examinador
LEIPZIG,MARC J
Unidade examinadora
M60
Localização atual
TMO LAW OFFICE 115
Descrição da marca
The mark consists of the wording "ALG PHARMA" in teal, appearing above three curved bands; a teal band is just above a light blue band, with a green hand appearing across the middle of the two.
Titulares e representantes
Titulares
AMADEITE
Representantes
Jeannine A Rittenhouse IpHorgan Ltd.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Seaweeds for use as fertilizers; algae for use as fertilizers; calcium-based algae nutrient supplements for use in aquariums; algae extracts for the manufacture of pharmaceutical productsin the nature of dietary food supplementspharmaceuticals and veterinary products; nutritive additive to enhance the biological activity of plants for purposes of fertilization and bioremediation of pollutants; seaweed and seaweed extracts for preventing infections in plants; chemical preparations of trace elements for preventing infections in plants; plant growth regulating preparations; cultures of microorganisms other than for medical and veterinary use; biological tissue cultures other than for medical or veterinary purposes * use * ; biological preparations for use in cell cultures other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary purposes * use * ; preparations of microorganisms other than for medical or veterinary use; chemical reagents other than for medical or veterinary use; chemical preparations for scientific use other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use * ; all the aforesaid goods being algae-based and none of these goods intended for use in connection with the treatment of allergiesasthmarhinitisanaphylactic reactions and other respiratory diseases *
Classe 5
Pharmaceutical productspharmaceutical preparations for the prevention and treatment of cancersof disorder of the central nervous systemof digestive disorderof respiratory disorderof urinary and sexual disorderof immunity system disorderof bone and joint disorderof mucosal and skin disorderof vascular and hemostasis disorderof infectious disease; sanitary preparations for medical purposes; dietetic foods adapted for medical purposes for human usecereals and cereal-based foods made with grains and flours in the nature of breadspastastortillassweet biscuitssavoury biscuitscakesdoughscrispbread and breakfast cerealsvegetables and vegetable-based foods made with texturized vegetable proteinleaf proteinssoyafungivegetable juicesalgaefruit juicesnuts and seeds and nut-based foodsfishmollusks and their eggscrustaceans and their eggsprocesseddriedsaltedsmoked and canned fishmeat and meat-based foods in the nature of processed meateggsmilk and milk-based foods and beverages in the nature of creamsyoghurtscheesesmilk-based cream desserts and ice creamssugars and syrups being confectionerydessertsjams jelliespreservesbeverages in the nature of teascoffeescordialssoft drinksfruit flavoured drinksherbsspices; food for babies; food supplements for humans; disinfectants; preparations for destroying vermin; fungicidesherbicidesparasiticides * ; all the aforesaid goods pertaining to the pharmaceutical sector * ; plant extracts for pharmaceutical use; medicinal plant extracts; diagnostic agents for medical purposes; living cells for medical use; stem cells for medical use; enzymes for medical use; bacteriological preparations for medical use; plant preparations being plan extracts for medical use; bacteriological preparations for medical use; biochemical preparations for medical purposesfor the prevention and treatment of cancersof disorder of the central nervous systemof digestive disorderof respiratory disorderof urinary and sexual disorderof immunity system disorderof bone and joint disorderof mucosal and skin disorderof vascular and hemostasis disorderof infectious disease; biological preparations for medical usefor the for the prevention and treatment of cancersof disorder of the central nervous systemof digestive disorderof respiratory disordersof urinary and sexual disordersof immunity system disorderof bone and joint disorderof mucosal and skin disorderof vascular and hemostasis disorderof infectious disease; biotechnological preparations for medical usefor the for the prevention and treatment of cancersof disorder of the central nervous systemof digestive disorderof respiratory disorderof urinary and sexual disorderof immunity system disorderof bone and joint disorderof mucosal and skin disorderof vascular and hemostasis disorderof infectious disease; alginates for pharmaceutical use; iodine for pharmaceutical use * ; all the aforesaid goods being algae-based and none of these goods intended for use in connection with the treatment of allergiesasthmarhinitisanaphylactic reactions and other respiratory diseases *
Classe 42
Chemical analysis ; scientific analysesscientific research and scientific laboratory services ; engineering services in the fields of science and technology provided by engineers; scientific and technical research in the fields of human healthhuman nutritionanimal welfareanimal healthanimal nutritionhorticulture and agriculturealgae-based products for food industry and human health; medical research; development of pharmaceutical preparations and medicines; research in the field of pharmaceuticals; research and development in the field of pharmaceuticals; conducting clinical trials for pharmaceutical products; research and development of new products for others in the field of pharmaceuticals; scientific research and development; research and development of vaccines and medicines; medical research laboratory services; conducting scientific feasibility studies * ; all the aforesaid services in connection with the study of algae and none of these services intended for use in connection with the treatment of allergiesasthmarhinitisanaphylactic reactions and other respiratory diseases *
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/12/2025
INPC
INVALIDATION PROCESSED
06/12/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/07/2025
C71T
CANCELLED SECTION 71
01/11/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
17/04/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
25/06/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/06/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
14/06/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
19/04/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
21/09/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
31/08/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
17/08/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/08/2018
FIMP
FINAL DISPOSITION PROCESSED
04/08/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/07/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
17/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/01/2018
PUBO
PUBLISHED FOR OPPOSITION
30/01/2018
GPNX
NOTIFICATION PROCESSED BY IB
26/01/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/01/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/01/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/01/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/12/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
21/12/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/12/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
21/12/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/12/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/07/2017
GNFR
FINAL REFUSAL E-MAILED
06/07/2017
CNFR
FINAL REFUSAL WRITTEN
06/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2017
RFNT
REFUSAL PROCESSED BY IB
24/12/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/12/2016
RFRR
REFUSAL PROCESSED BY MPU
07/12/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/11/2016
CNRT
NON-FINAL ACTION WRITTEN
23/11/2016
MAFR
APPLICATION FILING RECEIPT MAILED
22/11/2016
DOCK
ASSIGNED TO EXAMINER
18/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/11/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/11/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALG PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.